• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Risk versus reward

April 1, 2006
Steven Fox, DVM, PhD, MBA

When you decide to invest in the stock market, keep in mind something that professional analysts must remember: Investing always requires weighing potential risk against potential award.

When you decide to invest in the stock market, keep in mind something that professional analysts must remember: Investing always requires weighing potential risk against potential award.

In broad terms, analysts generally weigh three issues: fundamental business factors, the technical position of the stock and intangible factors that might provide a sense of how reliable a stock might be.

Business fundamentals are the first factors to consider. For example, does the company have a projected earnings growth rate that is substantially better than that of the Standard & Poors 500 Index? Is the company first or second in its industry in terms of market share of its products and services? If not, is it gaining market share against its larger competitors? Is the company the lowest-cost operator in the industry?

Advertisement

Technical analysts seek clues to a stock's future performance by charting its historical price and volume action. Questions they ask themselves include: Is the stock in a long-running uptrend? Are there signs that it might be building to a peak from which it is likely to fall? Is the industry sector in or out of favor with investors or consumers? Has the stock been displaying above-average relative strength compared to the broad market? Finally, does the stock trade in enough volume to make it relatively easy to buy and sell?

Some parts of the stock market are impossible to quantify. For example, does the company have a growth record that can capture the imagination of other investors? Does it seem likely it will attract institutional buyers?

On a more objective level, is the stock widely followed by Wall Street analysts? Or is it followed by only a few firms, possibly making it vulnerable to an analyst's downgrade?

Finally, you must consider the stock's performance history. What were the causes of any large sell-offs over the past decade? Were they related to company or industry developments or to the consequences of general market weakness?

Valuation

Is the stock you're considering just a trading vehicle, or are there enough positive answers to the previous questions to suggest that it may have the potential for an enduring rise? If your answer is the latter but the stock's price-to-earnings ratio (P/E) seems too high, there is another factor to consider: the further into the future that you can project a stream of growing earnings, the more likely it may be that the stock could trade at a high P/E ratio for an extended period of time, and quite possibly, outperform many issues that look less expensive.

All stocks won't measure up to these standards, but weighing these criteria when evaluating a stock can provide the potential for rewarding investments.

Dr. Fox has owned and operated a mixed animal practice in Taos, N.M. He is currently with Morgan Stanley in San Diego. He can be reached directly at (800) 473-1331; or e-mail: steven.fox@morganstanley.com

Related Content:

Practice OperationsBusiness
Build your first veterinary hospital
Build your first veterinary hospital
The Vets appoints Dr Zach Mills to VP of Medical Performance
The Vets appoints Dr Zach Mills to VP of Medical Performance
Purina announces its 2023 Pet Care Innovation Prize winners
Purina announces its 2023 Pet Care Innovation Prize winners

Advertisement

Latest News

Meet the BlackDVM Network

Study finds certain canine breeds should be screened for cancer at young ages

AVMA releases 2 videos informing pet parents on pet dental care

Clinical research: the oral microbiome for earlier disease detection

View More Latest News
Advertisement